Response to “Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer”

由 Daly, Louise E., Ryan, Aoife M., Power, Derek G.
發表在 J Clin Oncol (2016)

Loss of skeletal muscle during systemic chemotherapy is prognostic of poor survival in patients with foregut cancer

由 Daly, Louise E., Ní Bhuachalla, Éadaoin B., Power, Derek G., Cushen, Samantha J., James, Karl, Ryan, Aoife M.
發表在 J Cachexia Sarcopenia Muscle (2018)

Computed tomography diagnosed cachexia and sarcopenia in 725 oncology patients: is nutritional screening capturing hidden malnutrition?

由 Ní Bhuachalla, Éadaoin B., Daly, Louise E., Power, Derek G., Cushen, Samantha J., MacEneaney, Peter, Ryan, Aoife M.
發表在 J Cachexia Sarcopenia Muscle (2017)

The impact of body composition parameters on ipilimumab toxicity and survival in patients with metastatic melanoma

由 Daly, Louise E, Power, Derek G, O'Reilly, Áine, Donnellan, Paul, Cushen, Samantha J, O'Sullivan, Kathleen, Twomey, Maria, Woodlock, David P, Redmond, Henry P, Ryan, Aoife M
發表在 Br J Cancer (2017)

The Relationship between ECOG-PS, mGPS, BMI/WL Grade and Body Composition and Physical Function in Patients with Advanced Cancer

由 Dolan, Ross D., Daly, Louise E., Simmons, Claribel Pl., Ryan, Aoife M., Sim, Wei Mj., Fallon, Marie, Power, Derek G., Wilcock, Andrew, Maddocks, Matthew, Bennett, Michael I., Usborne, Caroline, Laird, Barry J., McMillan, Donald C.
發表在 Cancers (Basel) (2020)